Work

26-a-11163-acc Phase 1 Update: the Novel Oral Pcsk9 Inhibitor Enlicitide Does Not Affect the Pharmacokinetics of Narrow Therapeutic Index Concomitant Medications

Year: 2026

Type: article

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2026.02.664

Authors: Douglas G. Johns, Jeanette Alicea, Patrice Auger, Ednan Bajwa, Puja Banka, Piyali Basak, David Bruce, Josee Cote, Kiet Giang, Helen Manthos, Rahul Mishra, Shruti Patel, Maxwell Pistilli, Jonathan Pollock, Dennis Wolford, Michelle Valentine, Islam Younis

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Celerion (United States)

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7141421573

FWCI: 13.82

Cites:

Cited by: 4

Related to: 10